Fortuity Pharma
Pharmaceutical Manufacturing
Genetic Mutations. Under the Guidance of Their Physician
2 employees
- Employees
- 2
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Fortuity Pharma Overview
- Headquarters
- Genetic Mutations. Under the Guidance of Their Physician
- Website
- www.fortuitypharma.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 2
- Founded
- 2024
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
Keywords
About Fortuity Pharma
Fortuity Pharma is a public-benefit corporation dedicated to developing effective and affordable therapies for the rare disease community by repurposing existing drugs and nutraceuticals. Inspired by the story of Lucia, a patient with WOREE syndrome, the company was founded to bring the discontinued drug amlexanox back to market after it showed significant therapeutic potential in treating her condition caused by nonsense mutations leading to a premature termination codon. There is significant preclinical evidence this drug can read through premature stops during DNA translation to mRNA and then to protein synthesis in many rare diseases, so Fortuity Pharma is eager to leverage the established safety profile of this drug to develop effective treatments for patients with this genotype.
Fortuity Pharma Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
- Phone contacts
- 1
- 100.0% coverage
Fortuity Pharma Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Bruce Bloom | Founder, C-suite Executive, Speaker | Deerfield, Illinois, United States |
Email
Phone
|
Compare Similar Companies to Fortuity Pharma
Medics for Rare Disease
Non-Profit Organizations
Bright Path Laboratories
Pharmaceutical Manufacturing
Third Street Digital
Advertising Services
ThirtyFiveBio
Biotechnology Research
Oncoheroes Biosciences
Research Services
MICA AI Medical
Medical Equipment Manufacturing
Aspire Biosciences
Biotechnology Research
Animantis
Biotechnology Research
Migration Biotherapeutics Limited
Biotechnology Research
Karp Asset Management
Financial Services